Lamisil At Cream
Product Images NDC 84485-4030

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lamisil At Cream (NDC 84485-4030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Karo Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label (Image 01)

Carton-label (Image 01)
Lamisil AT Cream 1 g/100g topical antifungal cream packaging label by Karo Healthcare Inc. The label highlights its all-in-one use for athlete's foot, jock itch, and ringworm, and claims relief of itching, burning, cracking, and scaling. It includes usage directions, warnings, drug facts, a barcode, and contact information. The label states a net weight of 12 g (0.42 oz).*
FDA Label Image

Tube-label (Image 02)

Tube-label (Image 02)
Lamisil AT Cream 1% Terbinafine Hydrochloride topical antifungal cream in a 12 g (0.42 oz) tube. The label includes usage instructions for athlete's foot, jock itch, and ringworm, with directions for adults and children 12 years and over. Distributed by Karo Healthcare Inc., Morristown, NJ, USA. The label highlights antifungal use and warns against use on nails, scalp, or near eyes or mucous membranes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.